Antheia CEO and leadership

Christina Smolke is an American synthetic biologist whose primary research is in the use of yeast to produce opioids for medical use. She is a Full Professor of Bioengineering and of Chemical Engineering at Stanford University. She is the editor of The metabolic pathway engineering handbook (2010). She is an advisory board member for Integrative Biology.

Kristy has over 15 years of experience in the field of synthetic biology, focusing on yeast metabolic engineering for the production of small molecules. Since 2015, she has been a co-founder and executive at Antheia developing a microbial fermentation process to make plant-inspired medicines. Kristy is an expert in tool development, high-throughput screening, and pathway engineering.

Christina Smolke is an American synthetic biologist whose primary research is in the use of yeast to produce opioids for medical use. She is a Full Professor of Bioengineering and of Chemical Engineering at Stanford University. She is the editor of The metabolic pathway engineering handbook (2010). She is an advisory board member for Integrative Biology.

Kristy has over 15 years of experience in the field of synthetic biology, focusing on yeast metabolic engineering for the production of small molecules. Since 2015, she has been a co-founder and executive at Antheia developing a microbial fermentation process to make plant-inspired medicines. Kristy is an expert in tool development, high-throughput screening, and pathway engineering.